搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pasteurella multocida Valine--tRNA ligase (valS), partial CSB-YP861397ESG
CSB-EP861397ESG
CSB-BP861397ESG
CSB-MP861397ESG
CSB-EP861397ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Chondroitin synthase (fcbD), partial CSB-YP861398ESG
CSB-EP861398ESG
CSB-BP861398ESG
CSB-MP861398ESG
CSB-EP861398ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Transcriptional repressor NrdR (nrdR) CSB-YP861399ESG
CSB-EP861399ESG
CSB-BP861399ESG
CSB-MP861399ESG
CSB-EP861399ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Uncharacterized protein PM0682 (PM0682), partial CSB-YP861400ESG1
CSB-EP861400ESG1
CSB-BP861400ESG1
CSB-MP861400ESG1
CSB-EP861400ESG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Uncharacterized protein PM0657 (PM0657) CSB-YP861401ESG
CSB-EP861401ESG
CSB-BP861401ESG
CSB-MP861401ESG
CSB-EP861401ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Uncharacterized protein PM0614 (PM0614) CSB-YP861402ESG
CSB-EP861402ESG
CSB-BP861402ESG
CSB-MP861402ESG
CSB-EP861402ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Ribosomal RNA large subunit methyltransferase M (rlmM) CSB-YP861403ESG
CSB-EP861403ESG
CSB-BP861403ESG
CSB-MP861403ESG
CSB-EP861403ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Glycogen phosphorylase (glgP), partial CSB-YP861404ESG
CSB-EP861404ESG
CSB-BP861404ESG
CSB-MP861404ESG
CSB-EP861404ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida UPF0263 protein PM0536 (PM0536) CSB-YP861405ESG
CSB-EP861405ESG
CSB-BP861405ESG
CSB-MP861405ESG
CSB-EP861405ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida UPF0339 protein PM0519 (PM0519) CSB-YP861406ESG
CSB-EP861406ESG
CSB-BP861406ESG
CSB-MP861406ESG
CSB-EP861406ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida UPF0275 protein PM0493 (PM0493) CSB-YP861407ESG
CSB-EP861407ESG
CSB-BP861407ESG
CSB-MP861407ESG
CSB-EP861407ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida NADPH-dependent 7-cyano-7-deazaguanine reductase (queF) CSB-YP861408ESG
CSB-EP861408ESG
CSB-BP861408ESG
CSB-MP861408ESG
CSB-EP861408ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Phosphoglucosamine mutase (glmM) CSB-YP861409ESG
CSB-EP861409ESG
CSB-BP861409ESG
CSB-MP861409ESG
CSB-EP861409ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Alanine racemase (alr) CSB-YP861410ESG
CSB-EP861410ESG
CSB-BP861410ESG
CSB-MP861410ESG
CSB-EP861410ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida 50S ribosomal protein L3 glutamine methyltransferase (prmB) CSB-YP861411ESG
CSB-EP861411ESG
CSB-BP861411ESG
CSB-MP861411ESG
CSB-EP861411ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Biotin synthase (bioB) CSB-YP861412ESG
CSB-EP861412ESG
CSB-BP861412ESG
CSB-MP861412ESG
CSB-EP861412ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC (mnmC), partial CSB-YP861413ESG
CSB-EP861413ESG
CSB-BP861413ESG
CSB-MP861413ESG
CSB-EP861413ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Uncharacterized protein PM0310 (PM0310) CSB-YP861414ESG
CSB-EP861414ESG
CSB-BP861414ESG
CSB-MP861414ESG
CSB-EP861414ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Pyridoxamine kinase (pdxY) CSB-YP861415ESG
CSB-EP861415ESG
CSB-BP861415ESG
CSB-MP861415ESG
CSB-EP861415ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida 50S ribosomal protein L31 type B (rpmE2) CSB-YP861416ESG
CSB-EP861416ESG
CSB-BP861416ESG
CSB-MP861416ESG
CSB-EP861416ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>